(Q34590939)

3 August 2017

1 reference

title

Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing? (English)

1 reference

ORCID Public Data File 2021

3 August 2017

main subject

acute coronary syndrome

1 reference

1 reference

author name string

Hassan M E Azzazy

series ordinal

1

1 reference

3 August 2017

Robert H Christenson

series ordinal

2

1 reference

3 August 2017

publication date

1 February 2002

1 reference

3 August 2017

published in

Clinical Biochemistry

1 reference

3 August 2017

volume

35

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

13-27

1 reference

Chest pain centers: diagnosis of acute coronary syndromes.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Missed diagnoses of acute cardiac ischemia in the emergency department.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Myocardial markers of injury. Evolution and insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Coronary Plaque Disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Angioscopic Evaluation of Coronary-Artery Thrombi in Acute Coronary Syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Accuracy of imaging technologies in the diagnosis of acute cardiac ischemia in the emergency department: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Site-specific N-terminal auto-degradation of human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

The time of onset and severity of acidosis in myocardial ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Acute myocardial infarction in chest pain patients with nondiagnostic ECGs: serial CK-MB sampling in the emergency department. The Emergency Medicine Cardiac Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Prognostic value of a normal or nonspecific initial electrocardiogram in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Management of acute coronary syndromes based on risk stratification by biochemical markers: an idea whose time has come

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

An improved basis for enzymatic estimation of infarct size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Estimation of acute myocardial infarct size in man by serum CK-MB measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Prodromal angina limits infarct size. A role for ischemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Prodromal unstable angina in acute myocardial infarction: prognostic value of short- and long-term outcome and predictor of infarct size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900277-1

10.1016/S0009-9120(02)00277-1

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference